Invega Sustenna Paliperidone 150 mg Prolonged-Release Injection – 1.5ml

Invega Sustenna 150 mg / 1.5ml

 is a long-acting antipsychotic medicine containing Paliperidone Palmitate.

It is supplied as a prolonged-release suspension for intramuscular injection and is prescribed as part of the treatment of certain psychotic disorders, including schizophrenia in adults, according to the physician's assessment and treatment plan.

Its prolonged-release formulation allows paliperidone to be released gradually over time. The injection must be administered by a healthcare professional according to the prescribed dose and schedule.

Key Benefits

• Contains Paliperidone Palmitate.
• Long-acting antipsychotic medicine.
• Prolonged-release formulation.
• Used in the treatment of schizophrenia in adults when prescribed.
• Administered by intramuscular injection.
• Supplied in a prefilled syringe.
• Strength: 150 mg / 1.5ml.
• Prescription medicine.
• Administered under healthcare professional supervision.

How to Use

For intramuscular injection only by a qualified healthcare professional.

The dose and injection schedule are determined by the treating physician according to the patient's condition.

Do not self-administer or change the prescribed dose or schedule without consulting a doctor.

Suitable For

Adults prescribed long-acting paliperidone as part of the treatment of schizophrenia or other approved indications determined by a physician.

Active Ingredient

Paliperidone Palmitate

Equivalent to:

Paliperidone 150 mg / 1.5ml

Product Details

Brand / Trademark: Invega Sustenna

Active Ingredient: Paliperidone Palmitate

Strength: 150 mg / 1.5ml

Product Type: Long-acting antipsychotic

Dosage Form: Prolonged-release suspension for intramuscular injection

Route: Intramuscular injection

Presentation: Prefilled syringe

Use: As prescribed and supervised by a physician

Company: Janssen